DDrare: Database of Drug Development for Rare Diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
97	潰瘍性大腸炎	1

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2019-004208-37-BE (EUCTR)	03/08/2020	04/03/2020	Statins for treating ulcerative colitis through GI microbiome	Drug repurposing - Statins as microbiota modulating agents in ulcerative colitis - ReMiDy	There are two population groups, 20 healthy volunteers and at least 150 individuals diagnosed with mild/moderate active ulcerative colitis or are in remission.;Therapeutic area: Diseases [C] - Digestive System Diseases [C06]	Trade Name: Rosuvastatine EG Product Name: rosuvastatin INN or Proposed INN: rosuvastatin Other descriptive name: ROSUVASTATIN CALCIUM	UZ Leuven	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	400	Phase 3	Belgium

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

EUCTR2019-004208-37-BE
(EUCTR)

03/08/2020

04/03/2020

Statins for treating ulcerative colitis through GI microbiome

Drug repurposing - Statins as microbiota modulating agents in ulcerative colitis - ReMiDy

There are two population groups, 20 healthy volunteers and at least 150 individuals diagnosed with mild/moderate active ulcerative colitis or are in remission.;Therapeutic area: Diseases [C] - Digestive System Diseases [C06]

Trade Name: Rosuvastatine EG
Product Name: rosuvastatin
INN or Proposed INN: rosuvastatin
Other descriptive name: ROSUVASTATIN CALCIUM

UZ Leuven

NULL

Authorised-recruitment may be ongoing or finished

Female: yes
Male: yes

400

Phase 3

Belgium